Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

244 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Assessment of Patient Reported Outcomes (PROs) in Outpatients Taking Oral Anticancer Drugs Included in the Real-Life Oncoral Program.
Collomb B, Dubromel A, Caffin AG, Herledan C, Larbre V, Baudouin A, Cerutti A, Couturier L, Maire M, Karlin L, Maucort-Boulch D, Huot L, Dalle S, Bachy E, Ghesquieres H, Salles G, Couraud S, You B, Freyer G, Trillet-Lenoir V, Ranchon F, Rioufol C. Collomb B, et al. Among authors: karlin l. Cancers (Basel). 2022 Jan 28;14(3):660. doi: 10.3390/cancers14030660. Cancers (Basel). 2022. PMID: 35158928 Free PMC article.
Pregnancy and multiple myeloma are not antinomic.
Brisou G, Bouafia-Sauvy F, Karlin L, Lebras L, Salles G, Coiffier B, Michallet AS. Brisou G, et al. Among authors: karlin l. Leuk Lymphoma. 2013 Dec;54(12):2738-41. doi: 10.3109/10428194.2013.786069. Epub 2013 Apr 30. Leuk Lymphoma. 2013. PMID: 23488659 Review. No abstract available.
Monitoring NK cell activity in patients with hematological malignancies.
Viel S, Charrier E, Marçais A, Rouzaire P, Bienvenu J, Karlin L, Salles G, Walzer T. Viel S, et al. Among authors: karlin l. Oncoimmunology. 2013 Sep 1;2(9):e26011. doi: 10.4161/onci.26011. Epub 2013 Sep 12. Oncoimmunology. 2013. PMID: 24327939 Free PMC article. Review.
Refractory diffuse large B-cell lymphoma after first-line immuno-CT: Treatment options and outcomes.
Filliatre-Clement L, Maucort-Boulch D, Bourbon E, Karlin L, Safar V, Bachy E, Sesques P, Ferrant E, Bouafia F, Lazareth A, Ghergus D, Coiffier B, Traverse Glehen A, Salles G, Ghesquieres H, Sarkozy C. Filliatre-Clement L, et al. Among authors: karlin l. Hematol Oncol. 2018 May 2. doi: 10.1002/hon.2512. Online ahead of print. Hematol Oncol. 2018. PMID: 29722049
Commercial anti-CD19 CAR T cell therapy for patients with relapsed/refractory aggressive B cell lymphoma in a European center.
Sesques P, Ferrant E, Safar V, Wallet F, Tordo J, Dhomps A, Karlin L, Brisou G, Vercasson M, Hospital-Gustem C, Schwiertz V, Ranchon F, Rioufol C, Choquet M, Sujobert P, Ghergus D, Bouafia F, Golfier C, Lequeu H, Lazareth A, Novelli S, Devic P, Traverse Glehen A, Viel S, Venet F, Mialou V, Hequet O, Chauchet A, Arkam Y, Nicolas-Virelizier E, Peyrade F, Cavalieri D, Ader F, Ghesquières H, Salles G, Bachy E. Sesques P, et al. Among authors: karlin l. Am J Hematol. 2020 Nov;95(11):1324-1333. doi: 10.1002/ajh.25951. Epub 2020 Aug 25. Am J Hematol. 2020. PMID: 32744738 Free article. Clinical Trial.
Immunomodulatory drugs in multiple myeloma: Impact of the SCARMET (Self CARe and MEdication Toxicity) educational intervention on outpatients' knowledge to manage adverse effects.
Périchou J, Ranchon F, Herledan C, Huot L, Larbre V, Carpentier I, Lazareth A, Karlin L, Beny K, Vantard N, Schwiertz V, Caffin AG, Baudouin A, Sesques P, Brisou G, Ghesquières H, Salles G, Rioufol C. Périchou J, et al. Among authors: karlin l. PLoS One. 2020 Dec 4;15(12):e0243309. doi: 10.1371/journal.pone.0243309. eCollection 2020. PLoS One. 2020. PMID: 33275634 Free PMC article. Clinical Trial.
244 results